150 related articles for article (PubMed ID: 30863185)
1. E3 ubiquitin ligase Smurf2: a prognostic factor in microsatellite stable colorectal cancer.
Klupp F; Giese C; Halama N; Franz C; Lasitschka F; Warth A; Schmidt T; Kloor M; Ulrich A; Schneider M
Cancer Manag Res; 2019; 11():1795-1803. PubMed ID: 30863185
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1/c-myc axis.
Gao Q; Wang S; Zhang Z
Gene Ther; 2023 Feb; 30(1-2):51-63. PubMed ID: 34545207
[TBL] [Abstract][Full Text] [Related]
3. AAMP promotes colorectal cancermetastasis by suppressing SMURF2-mediatedubiquitination and degradation of RhoA.
Wu Y; Liu B; Lin W; Zhao R; Han W; Xie J
Mol Ther Oncolytics; 2021 Dec; 23():515-530. PubMed ID: 34901393
[TBL] [Abstract][Full Text] [Related]
4. Smurf2 E3 ubiquitin ligase modulates proliferation and invasiveness of breast cancer cells in a CNKSR2 dependent manner.
David D; Jagadeeshan S; Hariharan R; Nair AS; Pillai RM
Cell Div; 2014; 9():2. PubMed ID: 25191523
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome and Network Dissection of Microsatellite Stable and Highly Instable Colorectal Cancer.
Akbari V; Kallhor M; Mollashahi B; Movafagh A
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2445-2454. PubMed ID: 31450919
[TBL] [Abstract][Full Text] [Related]
6. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation.
Li Y; Yang D; Tian N; Zhang P; Zhu Y; Meng J; Feng M; Lu Y; Liu Q; Tong L; Hu L; Zhang L; Yang JY; Wu L; Tong X
J Biol Chem; 2019 Oct; 294(40):14745-14756. PubMed ID: 31409643
[TBL] [Abstract][Full Text] [Related]
8. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression.
David D; Surendran A; Thulaseedharan JV; Nair AS
BMC Cancer; 2018 Mar; 18(1):284. PubMed ID: 29534682
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.
Yu L; Dong L; Li H; Liu Z; Luo Z; Duan G; Dai X; Lin Z
Oncogene; 2020 May; 39(22):4450-4464. PubMed ID: 32361710
[TBL] [Abstract][Full Text] [Related]
11. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
[TBL] [Abstract][Full Text] [Related]
13. Tumor-suppressive role of Smad ubiquitination regulatory factor 2 in patients with colorectal cancer.
Sato N; Sakai N; Furukawa K; Takayashiki T; Kuboki S; Takano S; Ohira G; Miyauchi H; Matsubara H; Ohtsuka M
Sci Rep; 2022 Mar; 12(1):5495. PubMed ID: 35361871
[TBL] [Abstract][Full Text] [Related]
14. A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ.
Kikuchi T; Mimura K; Okayama H; Nakayama Y; Saito K; Yamada L; Endo E; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Kono K
Oncol Lett; 2019 Dec; 18(6):5977-5985. PubMed ID: 31788072
[TBL] [Abstract][Full Text] [Related]
15. The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells.
Dong S; Liu J; Li L; Wang H; Ma H; Zhao Y; Zhao J
Am J Physiol Cell Physiol; 2019 May; 316(5):C632-C640. PubMed ID: 30758996
[TBL] [Abstract][Full Text] [Related]
16. RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor β signaling.
Malonis RJ; Fu W; Jelcic MJ; Thompson M; Canter BS; Tsikitis M; Esteva FJ; Sánchez I
J Biol Chem; 2017 May; 292(18):7435-7451. PubMed ID: 28292929
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer.
Lee KS; Kwak Y; Ahn S; Shin E; Oh HK; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
Cancer Immunol Immunother; 2017 Jul; 66(7):927-939. PubMed ID: 28405764
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis.
Liu X; Gu X; Sun L; Flowers AB; Rademaker AW; Zhou Y; Kiyokawa H
BMC Cancer; 2014 Feb; 14():57. PubMed ID: 24485087
[TBL] [Abstract][Full Text] [Related]
19. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells.
Fukunaga E; Inoue Y; Komiya S; Horiguchi K; Goto K; Saitoh M; Miyazawa K; Koinuma D; Hanyu A; Imamura T
J Biol Chem; 2008 Dec; 283(51):35660-7. PubMed ID: 18927080
[TBL] [Abstract][Full Text] [Related]
20. Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer.
Koustas E; Sarantis P; Theoharis S; Saetta AA; Chatziandreou I; Kyriakopoulou G; Giannopoulou I; Michelli M; Schizas D; Papavassiliou AG; Karamouzis MV
Am J Clin Oncol; 2019 Oct; 42(10):767-776. PubMed ID: 31517637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
